Recent News

• 03.30.2026 - Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
• 03.11.2026 - Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
• 03.06.2026 - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.04.2026 - Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference
• 03.02.2026 - Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)
• 02.26.2026 - Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

Recent Filings

• 03.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.19.2026 - 4/A Statement of changes in beneficial ownership of securities
• 03.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2026 - 144 Report of proposed sale of securities
• 03.17.2026 - 144 Report of proposed sale of securities
• 03.12.2026 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 03.12.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.11.2026 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 03.11.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material